Literature DB >> 16525141

Clinical practice. Supraventricular tachycardia.

Etienne Delacrétaz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16525141     DOI： 10.1056/NEJMcp051145

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

Review 1.  Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.

Authors:  Sean P Colgan; Holger K Eltzschig
Journal:  Annu Rev Physiol       Date:  2011-11-19       Impact factor: 19.318

Review 2.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia.

Authors:  Almut Grenz; Dirk Homann; Holger K Eltzschig
Journal:  Antioxid Redox Signal       Date:  2011-04-11       Impact factor: 8.401

Review 3.  [How to approach the patient with supraventricular tachycardia in the EP lab: A systematic overview].

Authors:  D Steven; H Bonnemeier; T Deneke; H L Estner; C Kriatselis; M Kuniss; A Luik; H-R Neuberger; D-I Shin; P Sommer; R R Tilz; D Thomas; C von Bary; F Voss; L Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-06-02

4.  Health care utilization among adenosine-sensitive supraventricular tachycardia patients presenting to the emergency department.

Authors:  Thomas A Dewland; Adam Oesterle; John Stein; Gregory M Marcus
Journal:  J Interv Card Electrophysiol       Date:  2017-06-10       Impact factor: 1.900

Review 5.  Attenuating myocardial ischemia by targeting A2B adenosine receptors.

Authors:  Holger K Eltzschig; Stephanie K Bonney; Tobias Eckle
Journal:  Trends Mol Med       Date:  2013-03-26       Impact factor: 11.951

Review 6.  Cardiac arrhythmias in low- and middle-income countries.

Authors:  Philasande Mkoko; Ehete Bahiru; Olujimi A Ajijola; Aime Bonny; Ashley Chin
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

7.  Supraventricular tachycardia as a complication of severe diabetic ketoacidosis in an adolescent with new-onset type 1 diabetes.

Authors:  Bryan Padraig Finn; Brian Fraser; Susan M O'Connell
Journal:  BMJ Case Rep       Date:  2018-03-15

Review 8.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

9.  Extracellular adenosine signaling in molecular medicine.

Authors:  Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2013-02       Impact factor: 4.599

10.  Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo.

Authors:  Michael Koeppen; Tobias Eckle; Holger K Eltzschig
Journal:  PLoS One       Date:  2009-08-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.